2015 - All Press Releases

New open access journal npj Vaccines announced by Nature Publishing Group and The University of Texas Medical Branch

London | Galveston TX, 19 November 2015

From preventable diseases such as measles and mumps, to Ebola and HIV, new clinical trials and vaccine debate, a new journal, npj Vaccines, will be dedicated to highlighting the most important scientific advances in vaccine research and development.

The new open access journal has been announced today by Nature Publishing Group and The University of Texas Medical Branch at Galveston on behalf of its Sealy Center for Vaccine Development.

Martin Delahunty, Global Head of Partnership Journals, Open Research Group, Nature Publishing Group said: “We want to encourage decision-making about vaccines on the basis of up-to-date scientific research and evidence. The articles from npj Vaccines will be open access and therefore free to read at the point of publication. They can be read and shared by anyone across the globe, from scientific researchers to clinicians working in remote areas, and parents looking for the latest research on vaccinations.”

Editor-in-Chief Dr. Alan D. Barrett, director of the Sealy Center for Vaccine Development said: “We’re very excited to be a partner with Nature and together we plan on publishing significant new advances in vaccine research and development. One of our main goals is to share information that will help researchers who are looking for state-of-the-art research about vaccines. We want to become a prime source of up-to-date information about vaccine development and how vaccines are helping to improve our lives and saving the lives of millions of people around the globe.

Dr. Danny O. Jacobs, UTMB executive vice president and provost, and dean of the School of Medicine said: “I share Dr. Barrett's enthusiasm and excitement about our new partnership with Nature Publishing Group in recognition of our organizations' mutual interests and collective expertise. Without a doubt, there is a clear need for a high impact open access journal that focuses on identifying and reporting the most important and significant information on vaccines to control infectious diseases and non-infectious disease in the future."

The journal will publish a variety of research articles on human and veterinary vaccinations from discovery and basic science to nonclinical development of vaccines, vaccine formulation, AIDS vaccine, cancer/oncology vaccines, clinical evaluation of vaccines and vaccine safety, to mention just a few. 

Each original research article will include a lay summary that will summarize the key issues being addressed within the article with the goal of keeping the readership informed of advances in the field of vaccinology. 

Given the public health importance of vaccines, in addition to publishing high quality original research, npj Vaccines also publishes commentaries, news, research highlights, editorials, and correspondence from readers, to provide state-of-the-art information for all of those interested in vaccines.

The website for npj Vaccines can be found here and more information on the Nature Partner Journal programme can be found here.



Amy Bourke-Waite
Senior Communications Manager
Springer Nature
T: +44 (0)20 7843 4603 | M: +44 (0) 7703717212

Raul Reyes
Director of Media Relations
The University of Texas Medical Branch at Galveston
T: +1 (409) 747 0794 | C: +1 (409) 771 7841

About the Sealy Center for Vaccine Development

UTMB’s Sealy Center for Vaccine Development has been named a World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases. The designation by WHO makes UTMB only the second university in the Western Hemisphere to receive this designation. UTMB is only the seventh university in the world to receive WHO designation for vaccine expertise. UTMB is the only academic institution in the United States with a fully operational biosafety level four containment facility — the Galveston National Laboratory — where research on the world’s most deadly pathogens can be conducted under the strictest safety practices and procedures. UTMB is Texas’ first academic health center; it opened its doors in 1891 and today comprises four health science schools, three institutes for advanced study and a health system offering a full range of primary and specialized medical services throughout the Texas Gulf Coast region. UTMB is a part of the University of Texas System and a member of the Texas Medical Center.

About Nature Publishing Group (NPG)

Nature Publishing Group (NPG) is a publisher of high impact scientific information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences.

Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. NPG publishes a range of Nature research journals and Nature Reviews journals, and a range of prestigious academic and partner journals including society-owned publications. Online, nature.com provides over 10 million visitors per month with access to NPG publications and services, including news and comment from Nature, and the leading scientific jobs board Naturejobs. Scientific American is at the heart of NPG's consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the oldest continuously published magazine in the US and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 14 local language editions around the world it reaches over 5 million consumers and scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.

Throughout all its businesses NPG is dedicated to serving the scientific community and the wider scientifically interested general public. Part of joint venture Springer Nature, NPG is a global company with principal offices in London, New York, Shanghai and Tokyo, and offices in cities worldwide including Boston, San Francisco, Washington DC, Buenos Aires, Mexico City, Sao Paulo, Cairo, Dubai, Delhi, Mumbai, Hong Kong, Melbourne, Osaka, Seoul, Barcelona, Madrid, Basingstoke, Heidelberg, Munich and Paris. For more information, please go to www.nature.com.

About Springer Nature

Springer Nature is a leading global research, educational and professional publisher, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature is the world’s largest academic book publisher, publisher of the world’s highest impact journals and a pioneer in the field of open research. The company numbers almost 13,000 staff in over 50 countries and has a turnover of approximately €1.5 billion. Springer Nature was formed in 2015 through the merger of Nature Publishing Group, Palgrave Macmillan, Macmillan Education and Springer Science+Business Media. Find out more: www.springernature.com and follow @SpringerNature.